Do low energy availability and perimenopausal ovarian aging reduce ovulation and amplify estrogenic effects?

In the transition to menopause, the interplay between metabolic status and reproductive aging significantly impacts hormonal balance and tissue health.

Clinical and effectiveness evidence

The frequency of anovulatory cycles increases dramatically during perimenopause, often exceeding 60% in the late transition stage. This decline in ovulation is primarily driven by age-related changes in the hypothalamic-pituitary-ovarian (HPO) axis, including elevated baseline FSH and irregular GnRH/LH pulsatility as ovaries become less responsive.

• Ovulation and Progesterone: Clinical data shows a direct correlation between reduced ovulation frequency and low progesterone levels. Because the corpus luteum (the primary source of progesterone) only forms following ovulation, anovulatory cycles result in a state of progesterone deficiency. Studies indicate a 6.6% annual decline in luteal progesterone excretion as women progress through perimenopause.
• LEA Impact: Low energy availability (LEA) independently suppresses the HPO axis by reducing leptin signaling and increasing cortisol. Research confirms that LEA leads to impaired LH surge patterns and functional hypothalamic amenorrhea, which, when combined with perimenopausal aging, creates a cumulative suppressive effect on reproductive function.

Mechanistic explanations

The physiological consequences of reduced ovulation are driven by specific molecular pathways:

• HPO Axis Disruption: LEA and ovarian aging converge on the GnRH/LH pulse generator. LEA acts via metabolic sensors (leptin and kisspeptin neurons) to inhibit GnRH, while perimenopause involves a loss of the standard feedback loops that maintain regular cycles.
• Estrogen Dominance: Progesterone normally serves as a critical check on estrogen-induced cellular proliferation. It regulates progesterone receptor (PR) isoforms to activate cyclin-dependent kinase inhibitors, limiting epithelial growth in sensitive tissues like the breast.
• Environmental Synergies: In the absence of adequate progesterone, the inhibitory signal is lost, allowing "unopposed" estrogenic effects. This amplifies the impact of environmental endocrine-disrupting chemicals (EDCs), such as BPA, which can upregulate aromatase (CYP19A1) and increase local estradiol production. While there is no direct evidence that progesterone regulates the CYP1B1 metabolic pathway (which produces genotoxic 4-hydroxyestrone), the overall state of progesterone deficiency makes any biased estrogen metabolism clinically more significant due to the lack of protective progesterone signaling.

Bottom line

The combination of low energy availability and perimenopausal aging reduces ovulation frequency, leading to a significant loss of corpus luteum-derived progesterone. This hormonal shift creates a state of "estrogen dominance," where the lack of progesterone's regulatory check amplifies the proliferative and metabolic effects of both internal and environmental estrogens.